| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.48e-06 | 14 | 33 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity, RNA polymerase II-specific | 2.72e-06 | 560 | 33 | 8 | GO:0001228 | |
| GeneOntologyMolecularFunction | DNA-binding transcription activator activity | 2.95e-06 | 566 | 33 | 8 | GO:0001216 | |
| GeneOntologyMolecularFunction | low voltage-gated calcium channel activity | 7.94e-06 | 3 | 33 | 2 | GO:0008332 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 5.95e-05 | 46 | 33 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor activity, RNA polymerase II-specific | 6.22e-05 | 1412 | 33 | 10 | GO:0000981 | |
| GeneOntologyMolecularFunction | RNA polymerase II cis-regulatory region sequence-specific DNA binding | 1.35e-04 | 1244 | 33 | 9 | GO:0000978 | |
| GeneOntologyMolecularFunction | cis-regulatory region sequence-specific DNA binding | 1.59e-04 | 1271 | 33 | 9 | GO:0000987 | |
| GeneOntologyMolecularFunction | SUMO binding | 4.45e-04 | 19 | 33 | 2 | GO:0032183 | |
| GeneOntologyMolecularFunction | RNA polymerase II transcription regulatory region sequence-specific DNA binding | 4.48e-04 | 1459 | 33 | 9 | GO:0000977 | |
| GeneOntologyMolecularFunction | scaffold protein binding | 4.82e-04 | 93 | 33 | 3 | GO:0097110 | |
| GeneOntologyMolecularFunction | voltage-gated sodium channel activity | 8.40e-04 | 26 | 33 | 2 | GO:0005248 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 1.09e-03 | 123 | 33 | 3 | GO:0030165 | |
| GeneOntologyMolecularFunction | chromatin binding | 1.19e-03 | 739 | 33 | 6 | GO:0003682 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.25e-03 | 129 | 33 | 3 | GO:0005262 | |
| GeneOntologyMolecularFunction | molecular adaptor activity | 1.33e-03 | 1356 | 33 | 8 | GO:0060090 | |
| GeneOntologyMolecularFunction | calcium ion transmembrane transporter activity | 1.96e-03 | 151 | 33 | 3 | GO:0015085 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 2.00e-03 | 152 | 33 | 3 | GO:0022843 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 3.32e-03 | 182 | 33 | 3 | GO:0005244 | |
| GeneOntologyMolecularFunction | sodium channel activity | 3.34e-03 | 52 | 33 | 2 | GO:0005272 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 3.43e-03 | 184 | 33 | 3 | GO:0022832 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | 6.96e-03 | 465 | 33 | 4 | GO:0046873 | |
| GeneOntologyBiologicalProcess | pattern specification process | 1.04e-06 | 526 | 32 | 8 | GO:0007389 | |
| GeneOntologyBiologicalProcess | synaptic signaling | CACNA1A ERC2 DLGAP3 CACNA1G ARID1B SORBS2 NCAN IQSEC2 SYNGAP1 | 1.20e-05 | 976 | 32 | 9 | GO:0099536 |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 1.27e-05 | 343 | 32 | 6 | GO:0090596 | |
| GeneOntologyBiologicalProcess | anterior/posterior pattern specification | 3.66e-05 | 247 | 32 | 5 | GO:0009952 | |
| GeneOntologyBiologicalProcess | regulation of calcium ion-dependent exocytosis | 4.60e-05 | 45 | 32 | 3 | GO:0017158 | |
| GeneOntologyBiologicalProcess | exocytosis | 4.78e-05 | 434 | 32 | 6 | GO:0006887 | |
| GeneOntologyBiologicalProcess | calcium ion import across plasma membrane | 5.59e-05 | 48 | 32 | 3 | GO:0098703 | |
| GeneOntologyBiologicalProcess | calcium ion import into cytosol | 5.59e-05 | 48 | 32 | 3 | GO:1902656 | |
| GeneOntologyBiologicalProcess | inorganic ion import across plasma membrane | 6.67e-05 | 142 | 32 | 4 | GO:0099587 | |
| GeneOntologyBiologicalProcess | cardiac muscle hypertrophy | 6.67e-05 | 142 | 32 | 4 | GO:0003300 | |
| GeneOntologyBiologicalProcess | inorganic cation import across plasma membrane | 6.67e-05 | 142 | 32 | 4 | GO:0098659 | |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | 6.68e-05 | 931 | 32 | 8 | GO:0098916 | |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | 6.68e-05 | 931 | 32 | 8 | GO:0007268 | |
| GeneOntologyBiologicalProcess | synapse organization | 7.04e-05 | 685 | 32 | 7 | GO:0050808 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | 7.10e-05 | 939 | 32 | 8 | GO:0099537 | |
| GeneOntologyBiologicalProcess | striated muscle hypertrophy | 7.43e-05 | 146 | 32 | 4 | GO:0014897 | |
| GeneOntologyBiologicalProcess | muscle hypertrophy | 7.83e-05 | 148 | 32 | 4 | GO:0014896 | |
| GeneOntologyBiologicalProcess | regulated exocytosis | 7.96e-05 | 291 | 32 | 5 | GO:0045055 | |
| GeneOntologyBiologicalProcess | regionalization | 8.15e-05 | 478 | 32 | 6 | GO:0003002 | |
| GeneOntologyBiologicalProcess | cell growth involved in cardiac muscle cell development | 8.89e-05 | 56 | 32 | 3 | GO:0061049 | |
| GeneOntologyBiologicalProcess | physiological cardiac muscle hypertrophy | 8.89e-05 | 56 | 32 | 3 | GO:0003301 | |
| GeneOntologyBiologicalProcess | physiological muscle hypertrophy | 8.89e-05 | 56 | 32 | 3 | GO:0003298 | |
| GeneOntologyBiologicalProcess | ear morphogenesis | 9.13e-05 | 154 | 32 | 4 | GO:0042471 | |
| GeneOntologyBiologicalProcess | sensory organ development | 1.05e-04 | 730 | 32 | 7 | GO:0007423 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue development | 1.38e-04 | 327 | 32 | 5 | GO:0048738 | |
| GeneOntologyBiologicalProcess | neuron-neuron synaptic transmission | 1.52e-04 | 12 | 32 | 2 | GO:0007270 | |
| GeneOntologyBiologicalProcess | muscle system process | 1.70e-04 | 547 | 32 | 6 | GO:0003012 | |
| GeneOntologyBiologicalProcess | striated muscle tissue development | 1.86e-04 | 349 | 32 | 5 | GO:0014706 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | 1.90e-04 | 1390 | 32 | 9 | GO:0045944 | |
| GeneOntologyBiologicalProcess | muscle tissue development | 1.90e-04 | 558 | 32 | 6 | GO:0060537 | |
| GeneOntologyBiologicalProcess | neuromuscular process controlling balance | 2.04e-04 | 74 | 32 | 3 | GO:0050885 | |
| GeneOntologyBiologicalProcess | calcium-ion regulated exocytosis | 2.76e-04 | 82 | 32 | 3 | GO:0017156 | |
| GeneOntologyBiologicalProcess | muscle structure development | 2.84e-04 | 858 | 32 | 7 | GO:0061061 | |
| GeneOntologyBiologicalProcess | receptor clustering | 2.86e-04 | 83 | 32 | 3 | GO:0043113 | |
| GeneOntologyBiologicalProcess | import across plasma membrane | 4.24e-04 | 230 | 32 | 4 | GO:0098739 | |
| GeneOntologyBiologicalProcess | positive regulation of calcium ion-dependent exocytosis | 4.35e-04 | 20 | 32 | 2 | GO:0045956 | |
| GeneOntologyBiologicalProcess | calcium ion import | 4.67e-04 | 98 | 32 | 3 | GO:0070509 | |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | 4.78e-04 | 663 | 32 | 6 | GO:0050804 | |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | 4.82e-04 | 664 | 32 | 6 | GO:0099177 | |
| GeneOntologyBiologicalProcess | cell junction organization | 6.11e-04 | 974 | 32 | 7 | GO:0034330 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle tissue development | 6.84e-04 | 25 | 32 | 2 | GO:0003228 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 6.89e-04 | 112 | 32 | 3 | GO:0019226 | |
| GeneOntologyBiologicalProcess | regulation of presynaptic cytosolic calcium ion concentration | 7.40e-04 | 26 | 32 | 2 | GO:0099509 | |
| GeneOntologyBiologicalProcess | membrane depolarization | 8.63e-04 | 121 | 32 | 3 | GO:0051899 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell development | 8.83e-04 | 122 | 32 | 3 | GO:0055013 | |
| GeneOntologyBiologicalProcess | segmentation | 9.05e-04 | 123 | 32 | 3 | GO:0035282 | |
| GeneOntologyBiologicalProcess | ear development | 9.46e-04 | 285 | 32 | 4 | GO:0043583 | |
| GeneOntologyBiologicalProcess | heart development | 9.59e-04 | 757 | 32 | 6 | GO:0007507 | |
| GeneOntologyBiologicalProcess | secretion by cell | 1.03e-03 | 1064 | 32 | 7 | GO:0032940 | |
| GeneOntologyBiologicalProcess | inner ear morphogenesis | 1.04e-03 | 129 | 32 | 3 | GO:0042472 | |
| GeneOntologyBiologicalProcess | reflex | 1.05e-03 | 31 | 32 | 2 | GO:0060004 | |
| GeneOntologyBiologicalProcess | cardiac cell development | 1.11e-03 | 132 | 32 | 3 | GO:0055006 | |
| GeneOntologyBiologicalProcess | developmental cell growth | 1.16e-03 | 301 | 32 | 4 | GO:0048588 | |
| GeneOntologyBiologicalProcess | cardiac muscle tissue growth | 1.26e-03 | 138 | 32 | 3 | GO:0055017 | |
| GeneOntologyBiologicalProcess | neuromuscular synaptic transmission | 1.42e-03 | 36 | 32 | 2 | GO:0007274 | |
| GeneOntologyBiologicalProcess | membrane depolarization during action potential | 1.42e-03 | 36 | 32 | 2 | GO:0086010 | |
| GeneOntologyBiologicalProcess | heart growth | 1.54e-03 | 148 | 32 | 3 | GO:0060419 | |
| GeneOntologyBiologicalProcess | regulation of cell growth involved in cardiac muscle cell development | 1.58e-03 | 38 | 32 | 2 | GO:0061050 | |
| GeneOntologyBiologicalProcess | export from cell | 1.64e-03 | 1153 | 32 | 7 | GO:0140352 | |
| GeneOntologyBiologicalProcess | axonogenesis | 1.67e-03 | 566 | 32 | 5 | GO:0007409 | |
| GeneOntologyBiologicalProcess | maintenance of synapse structure | 1.75e-03 | 40 | 32 | 2 | GO:0099558 | |
| GeneOntologyBiologicalProcess | embryonic organ morphogenesis | 2.03e-03 | 351 | 32 | 4 | GO:0048562 | |
| GeneOntologyBiologicalProcess | regulation of regulated secretory pathway | 2.10e-03 | 165 | 32 | 3 | GO:1903305 | |
| GeneOntologyBiologicalProcess | positive regulation of neuroblast proliferation | 2.12e-03 | 44 | 32 | 2 | GO:0002052 | |
| GeneOntologyBiologicalProcess | secretion | 2.28e-03 | 1221 | 32 | 7 | GO:0046903 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 2.57e-03 | 177 | 32 | 3 | GO:0055007 | |
| GeneOntologyBiologicalProcess | regulation of nervous system development | 2.57e-03 | 625 | 32 | 5 | GO:0051960 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 5.19e-05 | 46 | 33 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | chromatin | 6.29e-05 | 1480 | 33 | 10 | GO:0000785 | |
| GeneOntologyCellularComponent | presynaptic active zone | 6.97e-05 | 141 | 33 | 4 | GO:0048786 | |
| GeneOntologyCellularComponent | calcium channel complex | 2.07e-04 | 73 | 33 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | glutamatergic synapse | 2.38e-04 | 817 | 33 | 7 | GO:0098978 | |
| GeneOntologyCellularComponent | dendrite | 3.21e-04 | 858 | 33 | 7 | GO:0030425 | |
| GeneOntologyCellularComponent | voltage-gated sodium channel complex | 3.24e-04 | 17 | 33 | 2 | GO:0001518 | |
| GeneOntologyCellularComponent | dendritic tree | 3.26e-04 | 860 | 33 | 7 | GO:0097447 | |
| GeneOntologyCellularComponent | somatodendritic compartment | 5.14e-04 | 1228 | 33 | 8 | GO:0036477 | |
| GeneOntologyCellularComponent | nuclear speck | 5.37e-04 | 431 | 33 | 5 | GO:0016607 | |
| GeneOntologyCellularComponent | presynaptic active zone cytoplasmic component | 5.99e-04 | 23 | 33 | 2 | GO:0098831 | |
| GeneOntologyCellularComponent | sodium channel complex | 9.55e-04 | 29 | 33 | 2 | GO:0034706 | |
| GeneOntologyCellularComponent | neuronal cell body | 1.75e-03 | 835 | 33 | 6 | GO:0043025 | |
| GeneOntologyCellularComponent | cell cortex region | 2.29e-03 | 45 | 33 | 2 | GO:0099738 | |
| GeneOntologyCellularComponent | nuclear body | 2.60e-03 | 903 | 33 | 6 | GO:0016604 | |
| GeneOntologyCellularComponent | postsynaptic density, intracellular component | 2.71e-03 | 49 | 33 | 2 | GO:0099092 | |
| GeneOntologyCellularComponent | cell body | 3.00e-03 | 929 | 33 | 6 | GO:0044297 | |
| GeneOntologyCellularComponent | PcG protein complex | 3.05e-03 | 52 | 33 | 2 | GO:0031519 | |
| GeneOntologyCellularComponent | postsynaptic specialization, intracellular component | 3.53e-03 | 56 | 33 | 2 | GO:0099091 | |
| GeneOntologyCellularComponent | cation channel complex | 5.97e-03 | 235 | 33 | 3 | GO:0034703 | |
| GeneOntologyCellularComponent | presynaptic active zone membrane | 6.73e-03 | 78 | 33 | 2 | GO:0048787 | |
| HumanPheno | Gaze-evoked horizontal nystagmus | 1.32e-05 | 18 | 14 | 3 | HP:0007979 | |
| HumanPheno | Hyperactivity | 3.25e-05 | 558 | 14 | 8 | HP:0000752 | |
| HumanPheno | Autism | 3.87e-05 | 264 | 14 | 6 | HP:0000717 | |
| HumanPheno | Attention deficit hyperactivity disorder | 4.55e-05 | 413 | 14 | 7 | HP:0007018 | |
| HumanPheno | Hypertonicity | 4.85e-05 | 162 | 14 | 5 | HP:0002388 | |
| HumanPheno | Limb hypertonia | 4.85e-05 | 162 | 14 | 5 | HP:0002509 | |
| HumanPheno | Atonic seizure | 9.45e-05 | 94 | 14 | 4 | HP:0010819 | |
| HumanPheno | Abnormality of upper lip vermillion | 9.68e-05 | 464 | 14 | 7 | HP:0011339 | |
| HumanPheno | Interictal epileptiform activity | 1.13e-04 | 319 | 14 | 6 | HP:0011182 | |
| HumanPheno | Interictal EEG abnormality | 1.25e-04 | 325 | 14 | 6 | HP:0025373 | |
| HumanPheno | Abnormal social development | DYRK1A CACNA1A CACNA1H CACNA1G ARID1B YY1 FOXG1 IQSEC2 SYNGAP1 | 1.48e-04 | 908 | 14 | 9 | HP:0025732 |
| HumanPheno | Short attention span | 1.94e-04 | 517 | 14 | 7 | HP:0000736 | |
| HumanPheno | Abnormality of pain sensation | 1.94e-04 | 113 | 14 | 4 | HP:0010832 | |
| HumanPheno | Abnormal demeanor | 2.05e-04 | 44 | 14 | 3 | HP:5200261 | |
| HumanPheno | Horizontal nystagmus | 2.07e-04 | 115 | 14 | 4 | HP:0000666 | |
| HumanPheno | Abnormal tongue physiology | 2.07e-04 | 115 | 14 | 4 | HP:0030810 | |
| HumanPheno | Reduced attention regulation | 2.16e-04 | 526 | 14 | 7 | HP:5200044 | |
| HumanPheno | EEG with focal epileptiform discharges | 2.29e-04 | 118 | 14 | 4 | HP:0011185 | |
| HumanPheno | Restricted or repetitive behaviors or interests | 2.49e-04 | 368 | 14 | 6 | HP:0031432 | |
| HumanPheno | Slanting of the palpebral fissure | 2.52e-04 | 739 | 14 | 8 | HP:0200006 | |
| HumanPheno | Intellectual disability, severe | 2.60e-04 | 371 | 14 | 6 | HP:0010864 | |
| HumanPheno | Perseverative thought | 2.84e-04 | 377 | 14 | 6 | HP:0030223 | |
| HumanPheno | Abnormal eating behavior | 3.13e-04 | 128 | 14 | 4 | HP:0100738 | |
| HumanPheno | Disordered formal thought process | 3.24e-04 | 386 | 14 | 6 | HP:0025769 | |
| HumanPheno | Abnormal lower lip morphology | 3.27e-04 | 242 | 14 | 5 | HP:0000178 | |
| HumanPheno | EEG with multifocal slow activity | 3.37e-04 | 52 | 14 | 3 | HP:0010844 | |
| HumanPheno | Thick lower lip vermilion | 3.95e-04 | 136 | 14 | 4 | HP:0000179 | |
| HumanPheno | Gaze-evoked nystagmus | 3.99e-04 | 55 | 14 | 3 | HP:0000640 | |
| HumanPheno | Abnormal thought pattern | 4.16e-04 | 404 | 14 | 6 | HP:5200269 | |
| HumanPheno | Steroetypic upper-extremity movements | 4.43e-04 | 57 | 14 | 3 | HP:5200018 | |
| HumanPheno | Abnormality of the chin | 4.44e-04 | 409 | 14 | 6 | HP:0000306 | |
| HumanPheno | Abnormal response to social norms | 4.71e-04 | 807 | 14 | 8 | HP:5200123 | |
| HumanPheno | Social disinhibition | 4.71e-04 | 807 | 14 | 8 | HP:5200029 | |
| HumanPheno | Disinhibition | 4.71e-04 | 807 | 14 | 8 | HP:0000734 | |
| HumanPheno | Inappropriate behavior | 4.71e-04 | 807 | 14 | 8 | HP:0000719 | |
| HumanPheno | Infection-related seizure | 5.05e-04 | 145 | 14 | 4 | HP:0032892 | |
| HumanPheno | Seizure precipitated by febrile infection | 5.05e-04 | 145 | 14 | 4 | HP:0032894 | |
| HumanPheno | Febrile seizure (within the age range of 3 months to 6 years) | 5.05e-04 | 145 | 14 | 4 | HP:0002373 | |
| HumanPheno | Impulsivity | 5.60e-04 | 149 | 14 | 4 | HP:0100710 | |
| HumanPheno | Myoclonic absence seizure | 6.26e-04 | 14 | 14 | 2 | HP:0011150 | |
| HumanPheno | Anteverted ears | 6.26e-04 | 14 | 14 | 2 | HP:0040080 | |
| HumanPheno | Absent speech | 6.29e-04 | 436 | 14 | 6 | HP:0001344 | |
| HumanPheno | Motor stereotypy | 6.43e-04 | 280 | 14 | 5 | HP:0000733 | |
| HumanPheno | Somatic sensory dysfunction | 6.53e-04 | 439 | 14 | 6 | HP:0003474 | |
| HumanPheno | Prominent lips | 6.66e-04 | 156 | 14 | 4 | HP:0000184 | |
| HumanPheno | Abnormally increased volition | 7.93e-04 | 869 | 14 | 8 | HP:5200263 | |
| HumanPheno | EEG with focal spike waves | 8.23e-04 | 16 | 14 | 2 | HP:0011197 | |
| HumanPheno | Absence seizures with special features | 8.23e-04 | 16 | 14 | 2 | HP:0011148 | |
| HumanPheno | Abnormal relationship | 8.23e-04 | 16 | 14 | 2 | HP:5200024 | |
| HumanPheno | Brain imaging abnormality | 8.62e-04 | 167 | 14 | 4 | HP:0410263 | |
| HumanPheno | Abnormality of the palpebral fissures | 8.65e-04 | 880 | 14 | 8 | HP:0008050 | |
| HumanPheno | Deficiency of speech development | 8.69e-04 | 463 | 14 | 6 | HP:0002116 | |
| HumanPheno | Impairment in personality functioning | DYRK1A CACNA1A CACNA1H CACNA1G ARID1B YY1 FOXG1 IQSEC2 SYNGAP1 | 9.12e-04 | 1141 | 14 | 9 | HP:0031466 |
| HumanPheno | Tongue thrusting | 9.32e-04 | 17 | 14 | 2 | HP:0100703 | |
| HumanPheno | Inappropriate crying | 1.05e-03 | 18 | 14 | 2 | HP:0030215 | |
| HumanPheno | Generalized non-motor (absence) seizure | 1.05e-03 | 176 | 14 | 4 | HP:0002121 | |
| HumanPheno | Autistic behavior | 1.05e-03 | 678 | 14 | 7 | HP:0000729 | |
| HumanPheno | Downslanted palpebral fissures | 1.27e-03 | 497 | 14 | 6 | HP:0000494 | |
| HumanPheno | Short nose | 1.27e-03 | 325 | 14 | 5 | HP:0003196 | |
| HumanPheno | Abnormal rapid eye movement sleep | 1.30e-03 | 20 | 14 | 2 | HP:0002494 | |
| HumanPheno | Sensory neuropathy | 1.35e-03 | 503 | 14 | 6 | HP:0000763 | |
| HumanPheno | Aggressive behavior | 1.55e-03 | 516 | 14 | 6 | HP:0000718 | |
| HumanPheno | Abnormal aggressive, impulsive or violent behavior | 1.55e-03 | 516 | 14 | 6 | HP:0006919 | |
| HumanPheno | Abnormal duodenum morphology | 1.58e-03 | 88 | 14 | 3 | HP:0002246 | |
| HumanPheno | EEG with abnormally slow frequencies | 1.58e-03 | 88 | 14 | 3 | HP:0011203 | |
| HumanPheno | Non-motor seizure | 1.60e-03 | 197 | 14 | 4 | HP:0033259 | |
| HumanPheno | Abnormality of central nervous system electrophysiology | 1.76e-03 | 738 | 14 | 7 | HP:0030178 | |
| HumanPheno | Involuntary movements | DYRK1A CACNA1A CACNA1H CACNA1G YY1 BEAN1 FOXG1 IQSEC2 SYNGAP1 | 1.82e-03 | 1248 | 14 | 9 | HP:0004305 |
| HumanPheno | Abnormal stomach morphology | 1.82e-03 | 742 | 14 | 7 | HP:0002577 | |
| HumanPheno | Gastrointestinal atresia | 1.85e-03 | 93 | 14 | 3 | HP:0002589 | |
| HumanPheno | Diagnostic behavioral phenotype | 1.90e-03 | 747 | 14 | 7 | HP:0025783 | |
| HumanPheno | Unsteady gait | 1.94e-03 | 357 | 14 | 5 | HP:0002317 | |
| HumanPheno | Abnormal volitional state | DYRK1A CACNA1A CACNA1H CACNA1G ARID1B YY1 FOXG1 IQSEC2 SYNGAP1 | 1.99e-03 | 1263 | 14 | 9 | HP:0025780 |
| HumanPheno | Abnormal motivation | DYRK1A CACNA1A CACNA1H CACNA1G ARID1B YY1 FOXG1 IQSEC2 SYNGAP1 | 1.99e-03 | 1263 | 14 | 9 | HP:5200275 |
| HumanPheno | EEG abnormality | 2.12e-03 | 548 | 14 | 6 | HP:0002353 | |
| HumanPheno | Saccadic smooth pursuit | 2.20e-03 | 26 | 14 | 2 | HP:0001152 | |
| HumanPheno | Simple febrile seizure | 2.37e-03 | 27 | 14 | 2 | HP:0011171 | |
| HumanPheno | Hyperinsulinemic hypoglycemia | 2.37e-03 | 27 | 14 | 2 | HP:0000825 | |
| HumanPheno | Abnormality of the pancreatic islet cells | 2.55e-03 | 28 | 14 | 2 | HP:0006476 | |
| HumanPheno | Reduced impulse control | 2.58e-03 | 1032 | 14 | 8 | HP:5200045 | |
| HumanPheno | Stereotypical hand wringing | 2.73e-03 | 29 | 14 | 2 | HP:0012171 | |
| HumanPheno | Midline hand movements | 2.73e-03 | 29 | 14 | 2 | HP:5200009 | |
| HumanPheno | Sacral dimple | 3.00e-03 | 110 | 14 | 3 | HP:0000960 | |
| HumanPheno | Bilateral tonic-clonic seizure | 3.01e-03 | 394 | 14 | 5 | HP:0002069 | |
| HumanPheno | Decreased fetal movement | 3.02e-03 | 234 | 14 | 4 | HP:0001558 | |
| HumanPheno | Poor head control | 3.06e-03 | 235 | 14 | 4 | HP:0002421 | |
| HumanPheno | Abnormality of endocrine pancreas physiology | 3.12e-03 | 31 | 14 | 2 | HP:0012093 | |
| MousePheno | abnormal hippocampus morphology | 2.53e-07 | 331 | 29 | 8 | MP:0000807 | |
| MousePheno | abnormal temporal lobe morphology | 2.90e-07 | 337 | 29 | 8 | MP:0000801 | |
| MousePheno | abnormal limbic system morphology | 6.93e-07 | 378 | 29 | 8 | MP:0004166 | |
| MousePheno | abnormal seizure response to inducing agent | 2.96e-06 | 201 | 29 | 6 | MP:0009357 | |
| MousePheno | abnormal hippocampus size | 4.73e-06 | 55 | 29 | 4 | MP:0008281 | |
| MousePheno | seizures | 6.78e-06 | 360 | 29 | 7 | MP:0002064 | |
| MousePheno | abnormal superior colliculus morphology | 1.04e-05 | 21 | 29 | 3 | MP:0000904 | |
| MousePheno | abnormal seizure response to pharmacological agent | 1.16e-05 | 147 | 29 | 5 | MP:0000950 | |
| MousePheno | convulsive seizures | 1.41e-05 | 153 | 29 | 5 | MP:0000947 | |
| MousePheno | abnormal cerebral hemisphere morphology | 2.09e-05 | 599 | 29 | 8 | MP:0008540 | |
| MousePheno | abnormal telencephalon morphology | 2.51e-05 | 812 | 29 | 9 | MP:0000787 | |
| MousePheno | abnormal behavioral response to xenobiotic | 3.44e-05 | 309 | 29 | 6 | MP:0009745 | |
| MousePheno | abnormal synaptic transmission | CACNA1A ERC2 DLGAP3 CACNA1H CACNA1G ARID1B SORBS2 NCAN IQSEC2 SYNGAP1 | 3.45e-05 | 1070 | 29 | 10 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | CACNA1A ERC2 DLGAP3 CACNA1H CACNA1G ARID1B SORBS2 NCAN IQSEC2 SYNGAP1 | 3.62e-05 | 1076 | 29 | 10 | MP:0021009 |
| MousePheno | abnormal channel response | 4.20e-05 | 33 | 29 | 3 | MP:0003484 | |
| MousePheno | abnormal tectum morphology | 5.02e-05 | 35 | 29 | 3 | MP:0006104 | |
| MousePheno | abnormal midbrain roof plate morphology | 5.02e-05 | 35 | 29 | 3 | MP:0006103 | |
| MousePheno | abnormal corpora quadrigemina morphology | 5.02e-05 | 35 | 29 | 3 | MP:0000899 | |
| MousePheno | decreased superior colliculus size | 6.20e-05 | 6 | 29 | 2 | MP:0002892 | |
| MousePheno | decreased social investigation | 6.45e-05 | 38 | 29 | 3 | MP:0021111 | |
| MousePheno | stereotypic behavior | 7.06e-05 | 214 | 29 | 5 | MP:0001408 | |
| MousePheno | nonconvulsive seizures | 7.53e-05 | 40 | 29 | 3 | MP:0000948 | |
| MousePheno | abnormal miniature excitatory postsynaptic currents | 9.11e-05 | 116 | 29 | 4 | MP:0004753 | |
| MousePheno | abnormal brainstem morphology | 9.33e-05 | 227 | 29 | 5 | MP:0005277 | |
| MousePheno | small hippocampus | 1.15e-04 | 46 | 29 | 3 | MP:0008283 | |
| MousePheno | cognitive inflexibility | 1.15e-04 | 8 | 29 | 2 | MP:0014115 | |
| MousePheno | abnormal nervous system development | DYRK1A CACNA1A NR4A3 ARID1B OTX1 YY1 FOXG1 IQSEC2 RNF111 ZIC3 | 1.36e-04 | 1257 | 29 | 10 | MP:0003861 |
| MousePheno | abnormal thalamus morphology | 1.85e-04 | 54 | 29 | 3 | MP:0000832 | |
| MousePheno | abnormal forebrain morphology | 2.18e-04 | 1072 | 29 | 9 | MP:0000783 | |
| MousePheno | decreased hippocampus volume | 2.26e-04 | 11 | 29 | 2 | MP:0020083 | |
| MousePheno | abnormal midbrain morphology | 2.52e-04 | 151 | 29 | 4 | MP:0000897 | |
| MousePheno | abnormal brain development | 2.58e-04 | 638 | 29 | 7 | MP:0000913 | |
| MousePheno | postnatal growth retardation | 3.15e-04 | 881 | 29 | 8 | MP:0001732 | |
| MousePheno | abnormal postnatal growth | 3.84e-04 | 907 | 29 | 8 | MP:0001731 | |
| MousePheno | abnormal social investigation | 4.04e-04 | 171 | 29 | 4 | MP:0001360 | |
| MousePheno | abnormal hippocampus pyramidal cell layer | 4.17e-04 | 71 | 29 | 3 | MP:0008284 | |
| MousePheno | abnormal cerebral cortex morphology | 5.15e-04 | 328 | 29 | 5 | MP:0000788 | |
| MousePheno | abnormal CNS synaptic transmission | 6.68e-04 | 985 | 29 | 8 | MP:0002206 | |
| MousePheno | retina ganglion cell degeneration | 6.95e-04 | 19 | 29 | 2 | MP:0008067 | |
| MousePheno | abnormal dentate gyrus morphology | 7.32e-04 | 86 | 29 | 3 | MP:0000812 | |
| MousePheno | social withdrawal | 8.52e-04 | 21 | 29 | 2 | MP:0001361 | |
| MousePheno | abnormal hippocampus layer morphology | 8.90e-04 | 92 | 29 | 3 | MP:0000813 | |
| MousePheno | decreased midbrain size | 1.02e-03 | 23 | 29 | 2 | MP:0012089 | |
| MousePheno | abnormal spike wave discharge | 1.11e-03 | 24 | 29 | 2 | MP:0008840 | |
| MousePheno | abnormal PQ interval | 1.11e-03 | 24 | 29 | 2 | MP:0011918 | |
| MousePheno | abnormal eye electrophysiology | 1.19e-03 | 228 | 29 | 4 | MP:0005551 | |
| MousePheno | abnormal excitatory postsynaptic potential | 1.20e-03 | 102 | 29 | 3 | MP:0002912 | |
| MousePheno | postnatal lethality | 1.25e-03 | 1084 | 29 | 8 | MP:0002082 | |
| MousePheno | abnormal neuron physiology | 1.29e-03 | 604 | 29 | 6 | MP:0004811 | |
| MousePheno | abnormal basal ganglion morphology | 1.34e-03 | 106 | 29 | 3 | MP:0006007 | |
| MousePheno | abnormal vocalization | 1.37e-03 | 237 | 29 | 4 | MP:0001529 | |
| MousePheno | abnormal dendrite morphology | 1.37e-03 | 237 | 29 | 4 | MP:0008143 | |
| MousePheno | sporadic seizures | 1.41e-03 | 27 | 29 | 2 | MP:0000951 | |
| MousePheno | abnormal social/conspecific interaction behavior | 1.58e-03 | 421 | 29 | 5 | MP:0002557 | |
| MousePheno | lethality during fetal growth through weaning, incomplete penetrance | 1.59e-03 | 1124 | 29 | 8 | MP:0011112 | |
| MousePheno | decreased susceptibility to induction of seizure by inducing agent | 1.63e-03 | 29 | 29 | 2 | MP:0012348 | |
| MousePheno | decreased susceptibility to pharmacologically induced seizures | 1.63e-03 | 29 | 29 | 2 | MP:0002887 | |
| MousePheno | thin cerebellar molecular layer | 1.74e-03 | 30 | 29 | 2 | MP:0000890 | |
| MousePheno | circling | 1.78e-03 | 117 | 29 | 3 | MP:0001394 | |
| MousePheno | increased susceptibility to pharmacologically induced seizures | 1.78e-03 | 117 | 29 | 3 | MP:0002906 | |
| MousePheno | increased susceptibility to induction of seizure by inducing agent | 1.83e-03 | 118 | 29 | 3 | MP:0012349 | |
| MousePheno | abnormal exploration in a new environment | 1.83e-03 | 647 | 29 | 6 | MP:0013189 | |
| MousePheno | abnormal midbrain size | 1.86e-03 | 31 | 29 | 2 | MP:0012088 | |
| MousePheno | abnormal cerebral cortex pyramidal cell morphology | 1.98e-03 | 32 | 29 | 2 | MP:0009969 | |
| MousePheno | postnatal lethality, incomplete penetrance | 2.17e-03 | 669 | 29 | 6 | MP:0011086 | |
| MousePheno | abnormal neuron number | 2.24e-03 | 456 | 29 | 5 | MP:0008946 | |
| MousePheno | absence seizures | 2.37e-03 | 35 | 29 | 2 | MP:0003216 | |
| MousePheno | abnormal response to new environment | 2.48e-03 | 687 | 29 | 6 | MP:0001413 | |
| MousePheno | abnormal hindbrain morphology | 2.93e-03 | 485 | 29 | 5 | MP:0000841 | |
| MousePheno | abnormal learning/memory/conditioning | 2.95e-03 | 1239 | 29 | 8 | MP:0002063 | |
| MousePheno | decreased brain size | 3.04e-03 | 295 | 29 | 4 | MP:0000774 | |
| MousePheno | abnormal cognition | 3.05e-03 | 1246 | 29 | 8 | MP:0014114 | |
| MousePheno | abnormal diencephalon morphology | 3.16e-03 | 298 | 29 | 4 | MP:0000830 | |
| MousePheno | abnormal cerebellar cortex morphology | 3.23e-03 | 300 | 29 | 4 | MP:0004097 | |
| MousePheno | abnormal long-term spatial reference memory | 3.24e-03 | 41 | 29 | 2 | MP:0008432 | |
| MousePheno | increased exploration in new environment | 3.61e-03 | 150 | 29 | 3 | MP:0001415 | |
| MousePheno | abnormal reflex | 3.86e-03 | 1294 | 29 | 8 | MP:0001961 | |
| MousePheno | environmentally induced seizures | 3.89e-03 | 45 | 29 | 2 | MP:0009358 | |
| MousePheno | decreased vocalization | 4.06e-03 | 46 | 29 | 2 | MP:0020351 | |
| Domain | VDCCAlpha1 | 5.44e-07 | 10 | 32 | 3 | IPR002077 | |
| Domain | VDCC_T_a1 | 8.52e-06 | 3 | 32 | 2 | IPR005445 | |
| Domain | Channel_four-helix_dom | 1.26e-04 | 57 | 32 | 3 | IPR027359 | |
| Domain | - | 1.26e-04 | 57 | 32 | 3 | 1.20.120.350 | |
| Domain | Homeobox | 6.56e-04 | 234 | 32 | 4 | PF00046 | |
| Domain | HOMEOBOX_1 | 6.77e-04 | 236 | 32 | 4 | PS00027 | |
| Domain | HOX | 6.88e-04 | 237 | 32 | 4 | SM00389 | |
| Domain | Homeobox_dom | 7.10e-04 | 239 | 32 | 4 | IPR001356 | |
| Domain | HOMEOBOX_2 | 7.10e-04 | 239 | 32 | 4 | PS50071 | |
| Domain | Ion_trans_dom | 9.66e-04 | 114 | 32 | 3 | IPR005821 | |
| Domain | Ion_trans | 9.66e-04 | 114 | 32 | 3 | PF00520 | |
| Domain | - | 9.72e-04 | 27 | 32 | 2 | 1.10.260.40 | |
| Domain | Lambda_DNA-bd_dom | 1.12e-03 | 29 | 32 | 2 | IPR010982 | |
| Domain | - | 1.33e-03 | 283 | 32 | 4 | 1.10.10.60 | |
| Domain | Homeodomain-like | 2.38e-03 | 332 | 32 | 4 | IPR009057 | |
| Domain | TF_fork_head_CS_2 | 2.81e-03 | 46 | 32 | 2 | IPR030456 | |
| Domain | TF_fork_head_CS_1 | 2.93e-03 | 47 | 32 | 2 | IPR018122 | |
| Domain | FORK_HEAD_3 | 3.18e-03 | 49 | 32 | 2 | PS50039 | |
| Domain | FH | 3.18e-03 | 49 | 32 | 2 | SM00339 | |
| Domain | FORK_HEAD_1 | 3.18e-03 | 49 | 32 | 2 | PS00657 | |
| Domain | FORK_HEAD_2 | 3.18e-03 | 49 | 32 | 2 | PS00658 | |
| Domain | Forkhead | 3.18e-03 | 49 | 32 | 2 | PF00250 | |
| Domain | Fork_head_dom | 3.18e-03 | 49 | 32 | 2 | IPR001766 | |
| Domain | Homeobox_CS | 3.90e-03 | 186 | 32 | 3 | IPR017970 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 8.52e-06 | 23 | 25 | 3 | M47666 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 1.10e-05 | 25 | 25 | 3 | M47948 | |
| Pathway | REACTOME_NCAM1_INTERACTIONS | 5.40e-05 | 42 | 25 | 3 | M7169 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 7.59e-05 | 47 | 25 | 3 | M19708 | |
| Pathway | BIOCARTA_PRC2_PATHWAY | 1.64e-04 | 11 | 25 | 2 | MM1548 | |
| Pathway | REACTOME_NCAM_SIGNALING_FOR_NEURITE_OUT_GROWTH | 1.82e-04 | 63 | 25 | 3 | M11187 | |
| Pathway | BIOCARTA_PRC2_PATHWAY | 2.71e-04 | 14 | 25 | 2 | M22025 | |
| Pathway | WP_TYPE_II_DIABETES_MELLITUS | 6.82e-04 | 22 | 25 | 2 | M39658 | |
| Pathway | KEGG_MATURITY_ONSET_DIABETES_OF_THE_YOUNG | 8.83e-04 | 25 | 25 | 2 | M18312 | |
| Pathway | KEGG_MEDICUS_REFERENCE_DEUBIQUITINATION_OF_H2AK119 | 9.56e-04 | 26 | 25 | 2 | M47923 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 9.56e-04 | 26 | 25 | 2 | MM14878 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.45e-03 | 32 | 25 | 2 | MM15326 | |
| Pathway | REACTOME_SMAD2_SMAD3_SMAD4_HETEROTRIMER_REGULATES_TRANSCRIPTION | 1.83e-03 | 36 | 25 | 2 | M633 | |
| Pathway | REACTOME_GENERIC_TRANSCRIPTION_PATHWAY | 1.86e-03 | 768 | 25 | 6 | MM14851 | |
| Pathway | REACTOME_RUNX1_INTERACTS_WITH_CO_FACTORS_WHOSE_PRECISE_EFFECT_ON_RUNX1_TARGETS_IS_NOT_KNOWN | 1.94e-03 | 37 | 25 | 2 | M27797 | |
| Pathway | REACTOME_RNA_POLYMERASE_II_TRANSCRIPTION | 2.02e-03 | 1387 | 25 | 8 | M734 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 2.37e-03 | 41 | 25 | 2 | MM14876 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 2.47e-03 | 1432 | 25 | 8 | M509 | |
| Pathway | REACTOME_REGULATION_OF_BETA_CELL_DEVELOPMENT | 2.49e-03 | 42 | 25 | 2 | M17541 | |
| Pathway | REACTOME_SMOOTH_MUSCLE_CONTRACTION | 2.61e-03 | 43 | 25 | 2 | M1429 | |
| Pathway | WP_RETT_SYNDROME | 3.24e-03 | 48 | 25 | 2 | M39759 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_ACTIVITY_OF_SMAD2_SMAD3_SMAD4_HETEROTRIMER | 3.65e-03 | 51 | 25 | 2 | M665 | |
| Pathway | KEGG_CALCIUM_SIGNALING_PATHWAY | 3.71e-03 | 178 | 25 | 3 | M2890 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | DYRK1A FAM76B SLC39A6 USP34 CCNT1 ERC2 NR4A3 DLGAP3 ARID1B OTX1 CBX4 NKD1 NKD2 PRICKLE3 ONECUT1 YY1 FOXG1 IQSEC2 MAFA RNF111 ZIC3 SYNGAP1 | 8.03e-25 | 1203 | 33 | 22 | 29180619 |
| Pubmed | 1.47e-15 | 33 | 33 | 7 | 19336002 | ||
| Pubmed | 3.11e-09 | 4 | 33 | 3 | 31800012 | ||
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 3.11e-09 | 4 | 33 | 3 | 21788606 | |
| Pubmed | 6.51e-08 | 9 | 33 | 3 | 16382099 | ||
| Pubmed | 1.25e-07 | 251 | 33 | 6 | 27507650 | ||
| Pubmed | 1.96e-07 | 963 | 33 | 9 | 28671696 | ||
| Pubmed | Impact of cytosine methylation on DNA binding specificities of human transcription factors. | 6.62e-07 | 544 | 33 | 7 | 28473536 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 23436820 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 14988077 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 21079360 | ||
| Pubmed | Viable mice with compound mutations in the Wnt/Dvl pathway antagonists nkd1 and nkd2. | 8.73e-07 | 2 | 33 | 2 | 17438140 | |
| Pubmed | Molecular cloning, gene structure, and expression analyses of NKD1 and NKD2. | 8.73e-07 | 2 | 33 | 2 | 11604995 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 21622683 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 31042060 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 11356022 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 20547676 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 22886848 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 20685979 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 29082441 | ||
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 22574369 | ||
| Pubmed | Blockade of T-type Ca(2+) channels inhibits human ovarian cancer cell proliferation. | 8.73e-07 | 2 | 33 | 2 | 21438841 | |
| Pubmed | 8.73e-07 | 2 | 33 | 2 | 22469755 | ||
| Pubmed | β-Adrenergic stimulation increases Cav3.1 activity in cardiac myocytes through protein kinase A. | 8.73e-07 | 2 | 33 | 2 | 22808078 | |
| Pubmed | A census of human transcription factors: function, expression and evolution. | 1.63e-06 | 908 | 33 | 8 | 19274049 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 24327205 | ||
| Pubmed | Ethanol inhibition of a T-type Ca²+ channel through activity of protein kinase C. | 2.62e-06 | 3 | 33 | 2 | 23488970 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 24966091 | ||
| Pubmed | PR72, a novel regulator of Wnt signaling required for Naked cuticle function. | 2.62e-06 | 3 | 33 | 2 | 15687260 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 26488564 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 26216687 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 31919478 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 25825486 | ||
| Pubmed | Differential interactions of Na+ channel toxins with T-type Ca2+ channels. | 2.62e-06 | 3 | 33 | 2 | 18591418 | |
| Pubmed | Identification of the t-type calcium channel (Ca(v)3.1d) in developing mouse heart. | 2.62e-06 | 3 | 33 | 2 | 11230107 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 11897840 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 28846697 | ||
| Pubmed | Caveolin-3 regulates protein kinase A modulation of the Ca(V)3.2 (alpha1H) T-type Ca2+ channels. | 2.62e-06 | 3 | 33 | 2 | 21084288 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 33547341 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 37739992 | ||
| Pubmed | Calmodulin regulates Cav3 T-type channels at their gating brake. | 2.62e-06 | 3 | 33 | 2 | 28972185 | |
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 11927664 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 29581247 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 22572848 | ||
| Pubmed | 2.62e-06 | 3 | 33 | 2 | 19266028 | ||
| Pubmed | 3.83e-06 | 709 | 33 | 7 | 22988430 | ||
| Pubmed | 4.75e-06 | 263 | 33 | 5 | 20932939 | ||
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 29996090 | ||
| Pubmed | Pharmacogenetics of antiepileptic drug efficacy in childhood absence epilepsy. | 5.23e-06 | 4 | 33 | 2 | 28165634 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 24912682 | ||
| Pubmed | Phase-separation mechanism for C-terminal hyperphosphorylation of RNA polymerase II. | 5.23e-06 | 4 | 33 | 2 | 29849146 | |
| Pubmed | 5.23e-06 | 4 | 33 | 2 | 28655554 | ||
| Pubmed | Role of the alpha1G T-type calcium channel in spontaneous absence seizures in mutant mice. | 5.23e-06 | 4 | 33 | 2 | 15175395 | |
| Pubmed | Deficient FGF signaling causes optic nerve dysgenesis and ocular coloboma. | 5.44e-06 | 36 | 33 | 3 | 23720040 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | 6.55e-06 | 281 | 33 | 5 | 28706196 | |
| Pubmed | Identification of 14-3-3epsilon substrates from embryonic murine brain. | 7.45e-06 | 132 | 33 | 4 | 16944949 | |
| Pubmed | 8.72e-06 | 5 | 33 | 2 | 12060068 | ||
| Pubmed | The mouse homolog of the orphan nuclear receptor tailless is expressed in the developing forebrain. | 8.72e-06 | 5 | 33 | 2 | 7720587 | |
| Pubmed | T-type calcium channels functionally interact with spectrin (α/β) and ankyrin B. | 8.72e-06 | 5 | 33 | 2 | 29720258 | |
| Pubmed | 9.36e-06 | 43 | 33 | 3 | 36950384 | ||
| Pubmed | 1.15e-05 | 46 | 33 | 3 | 34815492 | ||
| Pubmed | A novel function of Onecut1 protein as a negative regulator of MafA gene expression. | 1.31e-05 | 6 | 33 | 2 | 23775071 | |
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 23973221 | ||
| Pubmed | 1.31e-05 | 6 | 33 | 2 | 10804179 | ||
| Pubmed | An atlas of combinatorial transcriptional regulation in mouse and man. | 1.53e-05 | 877 | 33 | 7 | 20211142 | |
| Pubmed | BMP signaling is required for development of the ciliary body. | 1.83e-05 | 7 | 33 | 2 | 12223402 | |
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 19842177 | ||
| Pubmed | 1.83e-05 | 7 | 33 | 2 | 12900400 | ||
| Pubmed | Rebuilding essential active zone functions within a synapse. | 1.83e-05 | 7 | 33 | 2 | 35176221 | |
| Pubmed | 2.07e-05 | 1285 | 33 | 8 | 35914814 | ||
| Pubmed | Compartmentalization of the SUMO/RNF4 pathway by SLX4 drives DNA repair. | 2.08e-05 | 357 | 33 | 5 | 37059091 | |
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 28330839 | ||
| Pubmed | Onecut 1 and Onecut 2 are potential regulators of mouse retinal development. | 2.44e-05 | 8 | 33 | 2 | 21830221 | |
| Pubmed | 2.44e-05 | 8 | 33 | 2 | 34478646 | ||
| Pubmed | Longitudinal organization of the anterior neural plate and neural tube. | 2.44e-05 | 8 | 33 | 2 | 8575293 | |
| Pubmed | Intracellular calcium plays an essential role in cardiac development. | 2.44e-05 | 8 | 33 | 2 | 12761855 | |
| Pubmed | 2.57e-05 | 60 | 33 | 3 | 32027825 | ||
| Pubmed | 3.13e-05 | 9 | 33 | 2 | 30770380 | ||
| Pubmed | 3.13e-05 | 9 | 33 | 2 | 14704420 | ||
| Pubmed | TBR1 regulates autism risk genes in the developing neocortex. | 3.13e-05 | 9 | 33 | 2 | 27325115 | |
| Pubmed | Hmx2 homeobox gene control of murine vestibular morphogenesis. | 3.13e-05 | 9 | 33 | 2 | 11748138 | |
| Pubmed | 3.91e-05 | 10 | 33 | 2 | 31231191 | ||
| Pubmed | 3.91e-05 | 10 | 33 | 2 | 11731459 | ||
| Pubmed | 3.91e-05 | 10 | 33 | 2 | 11955708 | ||
| Pubmed | 3.91e-05 | 10 | 33 | 2 | 20652952 | ||
| Pubmed | 3.91e-05 | 10 | 33 | 2 | 24778262 | ||
| Pubmed | 4.46e-05 | 1431 | 33 | 8 | 37142655 | ||
| Pubmed | 4.78e-05 | 11 | 33 | 2 | 15509772 | ||
| Pubmed | Targeting HIV transcription: the quest for a functional cure. | 4.78e-05 | 11 | 33 | 2 | 25731772 | |
| Pubmed | 5.73e-05 | 12 | 33 | 2 | 23028343 | ||
| Pubmed | Myc cooperates with β-catenin to drive gene expression in nephron progenitor cells. | 5.73e-05 | 12 | 33 | 2 | 28993399 | |
| Pubmed | Identification of candidate proteins binding to prion protein. | 5.73e-05 | 12 | 33 | 2 | 9173930 | |
| Pubmed | Differential requirements for FGF3, FGF8 and FGF10 during inner ear development. | 5.73e-05 | 12 | 33 | 2 | 17601531 | |
| Pubmed | 6.77e-05 | 13 | 33 | 2 | 20702562 | ||
| Pubmed | 6.77e-05 | 13 | 33 | 2 | 21552538 | ||
| Pubmed | 6.77e-05 | 13 | 33 | 2 | 20941375 | ||
| Pubmed | The protein kinase DYRK1A regulates caspase-9-mediated apoptosis during retina development. | 6.77e-05 | 13 | 33 | 2 | 19081073 | |
| Pubmed | 7.89e-05 | 14 | 33 | 2 | 15546883 | ||
| Pubmed | Multiple, temporal-specific roles for HNF6 in pancreatic endocrine and ductal differentiation. | 7.89e-05 | 14 | 33 | 2 | 19766716 | |
| Pubmed | 7.89e-05 | 14 | 33 | 2 | 9811592 | ||
| Interaction | RNF4 interactions | DYRK1A FAM76B SLC39A6 USP34 CCNT1 ERC2 NR4A3 DLGAP3 ARID1B OTX1 CBX4 NKD1 NKD2 PRICKLE3 ONECUT1 YY1 FOXG1 IQSEC2 MAFA RNF111 ZIC3 SYNGAP1 | 1.12e-18 | 1412 | 32 | 22 | int:RNF4 |
| Interaction | KDM5B interactions | 2.63e-12 | 100 | 32 | 8 | int:KDM5B | |
| Interaction | FBLN5 interactions | 1.13e-10 | 159 | 32 | 8 | int:FBLN5 | |
| Interaction | KRTAP9-8 interactions | 1.05e-08 | 100 | 32 | 6 | int:KRTAP9-8 | |
| Interaction | KRTAP5-9 interactions | 2.58e-08 | 203 | 32 | 7 | int:KRTAP5-9 | |
| Interaction | KRTAP5-11 interactions | 6.07e-08 | 66 | 32 | 5 | int:KRTAP5-11 | |
| Interaction | KRTAP12-3 interactions | 1.01e-07 | 146 | 32 | 6 | int:KRTAP12-3 | |
| Interaction | KRTAP4-5 interactions | 1.24e-07 | 76 | 32 | 5 | int:KRTAP4-5 | |
| Interaction | KRTAP10-1 interactions | 1.34e-07 | 153 | 32 | 6 | int:KRTAP10-1 | |
| Interaction | KRTAP10-5 interactions | 1.74e-07 | 160 | 32 | 6 | int:KRTAP10-5 | |
| Interaction | GRN interactions | 2.37e-07 | 281 | 32 | 7 | int:GRN | |
| Interaction | KRTAP4-11 interactions | 3.25e-07 | 92 | 32 | 5 | int:KRTAP4-11 | |
| Interaction | KRTAP5-6 interactions | 3.61e-07 | 94 | 32 | 5 | int:KRTAP5-6 | |
| Interaction | PCSK5 interactions | 8.66e-07 | 112 | 32 | 5 | int:PCSK5 | |
| Interaction | KRTAP12-4 interactions | 1.45e-06 | 53 | 32 | 4 | int:KRTAP12-4 | |
| Interaction | KRTAP10-9 interactions | 1.92e-06 | 241 | 32 | 6 | int:KRTAP10-9 | |
| Interaction | KRTAP4-2 interactions | 1.95e-06 | 132 | 32 | 5 | int:KRTAP4-2 | |
| Interaction | KRTAP4-7 interactions | 2.01e-06 | 16 | 32 | 3 | int:KRTAP4-7 | |
| Interaction | KRTAP10-8 interactions | 2.57e-06 | 401 | 32 | 7 | int:KRTAP10-8 | |
| Interaction | KRTAP9-3 interactions | 2.61e-06 | 140 | 32 | 5 | int:KRTAP9-3 | |
| Interaction | KRTAP10-11 interactions | 3.11e-06 | 64 | 32 | 4 | int:KRTAP10-11 | |
| Interaction | KRTAP5-3 interactions | 3.52e-06 | 66 | 32 | 4 | int:KRTAP5-3 | |
| Interaction | KRTAP9-2 interactions | 3.54e-06 | 149 | 32 | 5 | int:KRTAP9-2 | |
| Interaction | KRTAP4-4 interactions | 7.99e-06 | 81 | 32 | 4 | int:KRTAP4-4 | |
| Interaction | CYSRT1 interactions | 1.26e-05 | 511 | 32 | 7 | int:CYSRT1 | |
| Interaction | CHRD interactions | 1.44e-05 | 94 | 32 | 4 | int:CHRD | |
| Interaction | FAM76B interactions | 1.77e-05 | 99 | 32 | 4 | int:FAM76B | |
| Interaction | SPRY1 interactions | 2.78e-05 | 111 | 32 | 4 | int:SPRY1 | |
| Interaction | VWC2L interactions | 3.45e-05 | 40 | 32 | 3 | int:VWC2L | |
| Interaction | CREBBP interactions | 3.49e-05 | 599 | 32 | 7 | int:CREBBP | |
| Interaction | NELL1 interactions | 4.00e-05 | 42 | 32 | 3 | int:NELL1 | |
| Interaction | ALPP interactions | 4.16e-05 | 123 | 32 | 4 | int:ALPP | |
| Interaction | EFEMP1 interactions | 4.16e-05 | 123 | 32 | 4 | int:EFEMP1 | |
| Interaction | KRTAP12-2 interactions | 4.86e-05 | 128 | 32 | 4 | int:KRTAP12-2 | |
| Interaction | EFEMP2 interactions | 6.16e-05 | 136 | 32 | 4 | int:EFEMP2 | |
| Interaction | ARHGEF15 interactions | 6.38e-05 | 49 | 32 | 3 | int:ARHGEF15 | |
| Interaction | SMAD3 interactions | 6.39e-05 | 447 | 32 | 6 | int:SMAD3 | |
| Interaction | TOX4 interactions | 7.29e-05 | 142 | 32 | 4 | int:TOX4 | |
| Interaction | RECK interactions | 7.62e-05 | 52 | 32 | 3 | int:RECK | |
| Interaction | EIF5A interactions | 7.78e-05 | 283 | 32 | 5 | int:EIF5A | |
| Interaction | KPRP interactions | 7.91e-05 | 284 | 32 | 5 | int:KPRP | |
| Interaction | ATXN2L interactions | 8.18e-05 | 286 | 32 | 5 | int:ATXN2L | |
| Interaction | TRIM42 interactions | 8.78e-05 | 149 | 32 | 4 | int:TRIM42 | |
| Interaction | MFAP1 interactions | 9.46e-05 | 295 | 32 | 5 | int:MFAP1 | |
| Interaction | EPB41L2 interactions | 1.01e-04 | 299 | 32 | 5 | int:EPB41L2 | |
| Interaction | YWHAE interactions | 1.05e-04 | 1256 | 32 | 9 | int:YWHAE | |
| Interaction | SHANK3 interactions | 1.13e-04 | 496 | 32 | 6 | int:SHANK3 | |
| Interaction | SYNGAP1 interactions | 1.14e-04 | 307 | 32 | 5 | int:SYNGAP1 | |
| Interaction | KRTAP6-3 interactions | 1.19e-04 | 161 | 32 | 4 | int:KRTAP6-3 | |
| Interaction | KRTAP4-12 interactions | 1.19e-04 | 161 | 32 | 4 | int:KRTAP4-12 | |
| Interaction | VWC2 interactions | 1.29e-04 | 62 | 32 | 3 | int:VWC2 | |
| Interaction | KRTAP5-2 interactions | 1.29e-04 | 62 | 32 | 3 | int:KRTAP5-2 | |
| Interaction | PPIL4 interactions | 1.30e-04 | 165 | 32 | 4 | int:PPIL4 | |
| Interaction | SART1 interactions | 1.33e-04 | 317 | 32 | 5 | int:SART1 | |
| Interaction | KRTAP12-1 interactions | 1.35e-04 | 63 | 32 | 3 | int:KRTAP12-1 | |
| Interaction | KRTAP5-4 interactions | 1.35e-04 | 63 | 32 | 3 | int:KRTAP5-4 | |
| Interaction | TAF2 interactions | 1.74e-04 | 178 | 32 | 4 | int:TAF2 | |
| Interaction | PPP1R10 interactions | 1.78e-04 | 179 | 32 | 4 | int:PPP1R10 | |
| Interaction | DLGAP1 interactions | 1.82e-04 | 180 | 32 | 4 | int:DLGAP1 | |
| Interaction | CHIC2 interactions | 2.10e-04 | 73 | 32 | 3 | int:CHIC2 | |
| Interaction | NALCN interactions | 2.20e-04 | 14 | 32 | 2 | int:NALCN | |
| Interaction | NSRP1 interactions | 2.57e-04 | 197 | 32 | 4 | int:NSRP1 | |
| Interaction | TSC1 interactions | 2.59e-04 | 366 | 32 | 5 | int:TSC1 | |
| Interaction | LCE4A interactions | 2.75e-04 | 80 | 32 | 3 | int:LCE4A | |
| Interaction | PLSCR2 interactions | 2.89e-04 | 16 | 32 | 2 | int:PLSCR2 | |
| Interaction | CBX4 interactions | 2.99e-04 | 205 | 32 | 4 | int:CBX4 | |
| Interaction | TNIK interactions | 3.11e-04 | 381 | 32 | 5 | int:TNIK | |
| Interaction | DDX42 interactions | 3.16e-04 | 208 | 32 | 4 | int:DDX42 | |
| Interaction | SMAD2 interactions | 3.26e-04 | 385 | 32 | 5 | int:SMAD2 | |
| Interaction | LGALS13 interactions | 3.27e-04 | 17 | 32 | 2 | int:LGALS13 | |
| Interaction | AGAP2 interactions | 3.28e-04 | 210 | 32 | 4 | int:AGAP2 | |
| Interaction | WDR82 interactions | 3.46e-04 | 213 | 32 | 4 | int:WDR82 | |
| Interaction | RB1 interactions | 3.63e-04 | 394 | 32 | 5 | int:RB1 | |
| Interaction | FAM53B interactions | 3.68e-04 | 18 | 32 | 2 | int:FAM53B | |
| Interaction | KRTAP1-1 interactions | 3.84e-04 | 219 | 32 | 4 | int:KRTAP1-1 | |
| Interaction | CCNT1 interactions | 4.26e-04 | 225 | 32 | 4 | int:CCNT1 | |
| Interaction | FIP1L1 interactions | 4.26e-04 | 225 | 32 | 4 | int:FIP1L1 | |
| Interaction | METTL17 interactions | 4.40e-04 | 411 | 32 | 5 | int:METTL17 | |
| Interaction | KRTAP2-3 interactions | 4.56e-04 | 95 | 32 | 3 | int:KRTAP2-3 | |
| Interaction | COMP interactions | 4.56e-04 | 20 | 32 | 2 | int:COMP | |
| Interaction | KALRN interactions | 4.70e-04 | 96 | 32 | 3 | int:KALRN | |
| Interaction | DBN1 interactions | 4.70e-04 | 417 | 32 | 5 | int:DBN1 | |
| Interaction | FAM76A interactions | 5.03e-04 | 21 | 32 | 2 | int:FAM76A | |
| Interaction | CRIM1 interactions | 5.03e-04 | 21 | 32 | 2 | int:CRIM1 | |
| Interaction | ESM1 interactions | 5.03e-04 | 21 | 32 | 2 | int:ESM1 | |
| Interaction | MDFI interactions | 5.41e-04 | 430 | 32 | 5 | int:MDFI | |
| Interaction | KRTAP2-4 interactions | 5.45e-04 | 101 | 32 | 3 | int:KRTAP2-4 | |
| Interaction | RBM15B interactions | 5.45e-04 | 101 | 32 | 3 | int:RBM15B | |
| Interaction | SIAH2 interactions | 5.94e-04 | 104 | 32 | 3 | int:SIAH2 | |
| Interaction | DCAF13 interactions | 6.05e-04 | 247 | 32 | 4 | int:DCAF13 | |
| Interaction | CACNB2 interactions | 6.05e-04 | 23 | 32 | 2 | int:CACNB2 | |
| Interaction | NCAN interactions | 6.60e-04 | 24 | 32 | 2 | int:NCAN | |
| Interaction | CSNK1D interactions | 6.71e-04 | 254 | 32 | 4 | int:CSNK1D | |
| Interaction | CPSF1 interactions | 6.81e-04 | 255 | 32 | 4 | int:CPSF1 | |
| Interaction | KAT2B interactions | 6.91e-04 | 256 | 32 | 4 | int:KAT2B | |
| Interaction | CDKL5 interactions | 7.56e-04 | 113 | 32 | 3 | int:CDKL5 | |
| Interaction | AKAP13 interactions | 8.16e-04 | 116 | 32 | 3 | int:AKAP13 | |
| Interaction | SATB1 interactions | 8.16e-04 | 116 | 32 | 3 | int:SATB1 | |
| Interaction | B4GALT2 interactions | 8.79e-04 | 119 | 32 | 3 | int:B4GALT2 | |
| Interaction | PTK2B interactions | 8.79e-04 | 119 | 32 | 3 | int:PTK2B | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p15 | 4.65e-04 | 44 | 33 | 2 | chr2p15 | |
| GeneFamily | Calcium voltage-gated channel subunits | 5.95e-06 | 26 | 25 | 3 | 253 | |
| GeneFamily | Forkhead boxes | 1.60e-03 | 43 | 25 | 2 | 508 | |
| Coexpression | BENPORATH_SUZ12_TARGETS | 3.69e-06 | 1035 | 33 | 9 | M9898 | |
| Coexpression | BENPORATH_ES_WITH_H3K27ME3 | 6.76e-06 | 1115 | 33 | 9 | M10371 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500_k-means-cluster#4 | 3.61e-05 | 121 | 33 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#2 | 3.79e-05 | 248 | 33 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#2 | 7.32e-05 | 145 | 33 | 4 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_500 | 9.88e-05 | 493 | 33 | 6 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500 | 1.02e-04 | 496 | 33 | 6 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000 | 1.03e-04 | 986 | 33 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000 | 1.06e-04 | 989 | 33 | 8 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.10e-04 | 732 | 33 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_2500_K5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ Genital tubercle_emap-6706_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.53e-04 | 67 | 33 | 3 | gudmap_developingLowerUrinaryTract_e14.5_ Genital tubercle_1000_k3 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.58e-04 | 177 | 33 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_1000_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_1000_k-means-cluster#3 | 1.66e-04 | 339 | 33 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_1000_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_500_k-means-cluster#2 | 1.82e-04 | 71 | 33 | 3 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | 1.92e-04 | 350 | 33 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_2500_K5 | |
| CoexpressionAtlas | BM Top 100 - amygdala | 1.97e-04 | 73 | 33 | 3 | BM Top 100 - amygdala | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | 2.34e-04 | 196 | 33 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_1000_K2 | |
| CoexpressionAtlas | cerebral cortex | 2.42e-04 | 1428 | 33 | 9 | cerebral cortex | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500_k-means-cluster#2 | 2.50e-04 | 79 | 33 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 3.15e-04 | 212 | 33 | 4 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500_k-means-cluster#4 | 3.66e-04 | 90 | 33 | 3 | Facebase_RNAseq_e8.5_Floor Plate_500_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.72e-04 | 893 | 33 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Facial Mesenchyne_top-relative-expression-ranked_1000_k-means-cluster#4 | 3.82e-04 | 223 | 33 | 4 | Facebase_RNAseq_e9.5_Facial Mesenchyne_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#1 | 4.40e-04 | 419 | 33 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K1 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.43e-04 | 232 | 33 | 4 | Facebase_RNAseq_e9.5_Maxillary Arch_1000_K4 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_top-relative-expression-ranked_100 | 4.85e-04 | 99 | 33 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Medial Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_100 | 4.99e-04 | 100 | 33 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_2500_k-means-cluster#3 | 5.90e-04 | 447 | 33 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_2500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_1000 | 6.34e-04 | 976 | 33 | 7 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000 | 6.62e-04 | 983 | 33 | 7 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Central Eminence_top-relative-expression-ranked_500_k-means-cluster#3 | 8.08e-04 | 118 | 33 | 3 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Central Eminence_500_K3 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Non-Floor Plate Neural Epithelium_top-relative-expression-ranked_500 | 8.84e-04 | 489 | 33 | 5 | Facebase_RNAseq_e8.5_Non-Floor Plate Neural Epithelium_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_1000_k-means-cluster#2 | 8.90e-04 | 122 | 33 | 3 | Facebase_RNAseq_e8.5_Floor Plate_1000_K2 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Medial Nasal Eminence_top-relative-expression-ranked_1000_k-means-cluster#5 | 9.33e-04 | 124 | 33 | 3 | Facebase_RNAseq_e10.5_Medial Nasal Eminence_1000_K5 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_500 | 9.34e-04 | 495 | 33 | 5 | Facebase_RNAseq_e8.5_Floor Plate_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_500 | 9.59e-04 | 498 | 33 | 5 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_500 | |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_1000_k-means-cluster#1 | 1.00e-03 | 127 | 33 | 3 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_1000_K1 | |
| ToppCell | RV-13._Vascular_Smooth_Muscle|RV / Chamber and Cluster_Paper | 5.96e-06 | 161 | 33 | 4 | 47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1 | |
| ToppCell | BAL-Mild-cDC_0|Mild / Compartment, Disease Groups and Clusters | 6.26e-06 | 163 | 33 | 4 | 7047d3ba847930f42a6d5f71e18d49f3071c6409 | |
| ToppCell | RA-07._Pericyte|RA / Chamber and Cluster_Paper | 9.46e-06 | 181 | 33 | 4 | 8dfb42d096db6c2df9b41303a7199d134d4bff07 | |
| ToppCell | RA-07._Pericyte|World / Chamber and Cluster_Paper | 9.67e-06 | 182 | 33 | 4 | 2075efeae633550fb2eb026d0dfd741c8252482e | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.03e-05 | 185 | 33 | 4 | 30df02fbe2828e3c4f3e5c4cda855e74fb31be39 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.08e-05 | 187 | 33 | 4 | 8ff9f771d10c372d771c92dfa9006aa81aec4681 | |
| ToppCell | Mesenchymal_cells-Smooth_muscle|World / Lineage and Cell class | 1.15e-05 | 190 | 33 | 4 | 5aa62a363a25f4a110136263b21289a11e8c1e6d | |
| ToppCell | (09)_Ionocytes-(3)_72hpi|(09)_Ionocytes / shred by cell type and Timepoint | 7.35e-05 | 110 | 33 | 3 | fce7d5a0617fc664b657f5bb9abb290e7cc234cb | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_ascending_limb_epithelial_cell-Ascending_Thin_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.21e-04 | 130 | 33 | 3 | 1720f16ac06951c3f57b6c3b0944670a571203d1 | |
| ToppCell | RA-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.44e-04 | 138 | 33 | 3 | 5a713f24f633de463ef47ca37fbb2bb60c7fdb77 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 158 | 33 | 3 | 0edd9b005875f9a4f5446f5d5161f8ba63860793 | |
| ToppCell | facs-Marrow-KLS-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.15e-04 | 158 | 33 | 3 | 9fd77ebdd1babf1c85a85d38d9a15858ab08bc84 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.19e-04 | 159 | 33 | 3 | 2f6c60ddff2208a68146f9786143d9aefd528840 | |
| ToppCell | BAL-Mild-Myeloid-cDC-cDC-cDC_0|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.19e-04 | 159 | 33 | 3 | ded4e3626a62fb6334403b7213b467fb7e8131c3 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 162 | 33 | 3 | 966df4558140c3d541999ab553f201ae76a1c401 | |
| ToppCell | facs-Marrow-T_cells-18m-Lymphocytic-immature_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-04 | 162 | 33 | 3 | 22f1abd20f43bc7e7fc46969da9962faf70ae5d2 | |
| ToppCell | LV-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.44e-04 | 165 | 33 | 3 | f37fd95adc95d7753cf6e55ae819976513c7ec77 | |
| ToppCell | droplet-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-04 | 167 | 33 | 3 | 774f3264318b002d0df5d06d41d645366038d0bf | |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Epithelial-neuro-epithelial-L_cells_(PYY+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.57e-04 | 168 | 33 | 3 | 0f736d58cb0ff042fa3ce58e36bde37b6976f8fc | |
| ToppCell | -Donor_05|World / lung cells shred on cell class, cell subclass, sample id | 2.61e-04 | 169 | 33 | 3 | 8ebe9a88111c53a09c25a7b6a164a0a17880458d | |
| ToppCell | Mild_COVID-19-Myeloid-MoAM5|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30） | 2.66e-04 | 170 | 33 | 3 | b2daf46ab5a49590ede8f75e4240bfe6e9d8b764 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Neuronal-neurons_B-Branch_B1_(eMN)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.85e-04 | 174 | 33 | 3 | 271c51d220842402975d97c86c9acfdbdf62a32c | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 174 | 33 | 3 | 197686570cec6d96a92e77e6409325d3bfe6f991 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-04 | 174 | 33 | 3 | 2eee7b5471672b439f95eba11494c2adf8cb7006 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-04 | 175 | 33 | 3 | 798f33bd340261c048b7b45c842b2ccd1ea1fb60 | |
| ToppCell | 5'-Adult-LymphNode-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.90e-04 | 175 | 33 | 3 | 294a70786260c9a2b1ba16c88819d786698609e7 | |
| ToppCell | 3'-Adult-LargeIntestine-Epithelial-neuro-epithelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.09e-04 | 179 | 33 | 3 | f93e81a3fd94adedb24a9db4ac1d53e275bbf8b5 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Hematopoietic-Myeloid-pDC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.09e-04 | 179 | 33 | 3 | bbd4f8e988ef3f343aaedbc992b70f2bb6aff5f6 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-04 | 180 | 33 | 3 | 9b1de1b4711adbf9a423f4d2d08f3f4c78f1f8f4 | |
| ToppCell | Control-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.15e-04 | 180 | 33 | 3 | 08ae0f5d95c45feba68ad99788f7af7ff4c979af | |
| ToppCell | TCGA-Skin-Metastatic-Melanoma-Skin_Cutaneous_Melanoma-2|TCGA-Skin / Sample_Type by Project: Shred V9 | 3.20e-04 | 181 | 33 | 3 | 9d5b331cabc5524f0a9fd8b571e87be4c447c7d4 | |
| ToppCell | VE-matDC-|VE / Condition, Cell_class and T cell subcluster | 3.20e-04 | 181 | 33 | 3 | 6252184ef098b911df50be4fe1b5565849a5b6b8 | |
| ToppCell | VE-matDC|VE / Condition, Cell_class and T cell subcluster | 3.20e-04 | 181 | 33 | 3 | 982fd96ef75bc9ab2c2f4970c01b76ba7a164871 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 3.30e-04 | 183 | 33 | 3 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | CV-Healthy-7|CV / Virus stimulation, Condition and Cluster | 3.35e-04 | 184 | 33 | 3 | 0e5cc77aaa73ceb791f8be7456177577fd2e5586 | |
| ToppCell | Mesenchymal_cells-Smooth_muscle|Mesenchymal_cells / Lineage and Cell class | 3.35e-04 | 184 | 33 | 3 | 83987abaedc26e6da477bc70d65e10b1ab1aea60 | |
| ToppCell | CV-Healthy-7|Healthy / Virus stimulation, Condition and Cluster | 3.41e-04 | 185 | 33 | 3 | 1979d189c204f4c2893e3170a514ee7d5523406c | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.41e-04 | 185 | 33 | 3 | ca69499ba8c39b7ed6717d05685d6f70066a77bd | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.46e-04 | 186 | 33 | 3 | 7278a1a1bf9bb27aeb03852134defb31b62f30d6 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_Arw_fibro_(16)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 3.52e-04 | 187 | 33 | 3 | 5258674d0346e5c51a4b965efcdc1790c970845d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D175|Adult / Lineage, Cell type, age group and donor | 3.52e-04 | 187 | 33 | 3 | e15d2967aac248da3517bc2c7d1beaa1d5a0aa7f | |
| ToppCell | Control-Fibroblasts-Alveolar_FB|Control / group, cell type (main and fine annotations) | 3.52e-04 | 187 | 33 | 3 | 92d468dde81125d51daf7abd4703741abe1ab91c | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.57e-04 | 188 | 33 | 3 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.68e-04 | 190 | 33 | 3 | 6ea9fa08bd97bedcb21d3654467e7f8dd74c8fd0 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.74e-04 | 191 | 33 | 3 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 191 | 33 | 3 | 8e8beb8e8a3b33cac83d3f7ce915a71e3654fdab | |
| ToppCell | droplet-Limb_Muscle-Pre-Sort-18m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 191 | 33 | 3 | 60bc1f3efa7bbad5cb7944fe5e049ea79cd1745a | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.74e-04 | 191 | 33 | 3 | 8597a8af294f24496c317d995f07eb5dcc25c13c | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.74e-04 | 191 | 33 | 3 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.80e-04 | 192 | 33 | 3 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.80e-04 | 192 | 33 | 3 | deeecd26972241846b4cb998edf0c7a87ff0c4df | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 3.86e-04 | 193 | 33 | 3 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | Mesenchymal-matrix_fibroblast_1_cell|World / Lineage, Cell type, age group and donor | 3.86e-04 | 193 | 33 | 3 | acad568621ed677031797b8c2e34dafea798d681 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-04 | 193 | 33 | 3 | be28070c049e7cb68bcd54f582226eb2f5e4bc1c | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.86e-04 | 193 | 33 | 3 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-nan|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-04 | 193 | 33 | 3 | 0c652ebe22ce5d2927599dd97ef1920547858395 | |
| ToppCell | droplet-Limb_Muscle-nan-24m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-04 | 193 | 33 | 3 | b9e11cd0896c0868aab7faec4ab7ab4d4e4d1b47 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-24m-Neuronal-neuron|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.86e-04 | 193 | 33 | 3 | 8689a70a33a7c3823dc647d41ac0160e7c3ae396 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.86e-04 | 193 | 33 | 3 | 99525545552b371c86b18b6ea6f4897dc6e9a9ec | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.86e-04 | 193 | 33 | 3 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.92e-04 | 194 | 33 | 3 | 35f132cc38ac133be01834ed0946188aa0757eb4 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-smooth_muscle_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.92e-04 | 194 | 33 | 3 | b8a130ffae68ffe550bf335460a1ec1035cf8d8d | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.92e-04 | 194 | 33 | 3 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Control-Stromal-Myofibroblast|World / Disease state, Lineage and Cell class | 3.92e-04 | 194 | 33 | 3 | 3c2266772c5b56e8e02a461e5193e29588028ee9 | |
| ToppCell | Control-Stromal-Myofibroblast|Control / Disease state, Lineage and Cell class | 3.97e-04 | 195 | 33 | 3 | ffcf76cd72e43d8cf1058a49c76e0956065038bc | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell|Adult / Lineage, Cell type, age group and donor | 3.97e-04 | 195 | 33 | 3 | 61c9e09fc84d1012e472185d70ad0a06cee30d6e | |
| ToppCell | COVID-19-Fibroblasts-Alveolar_FB|COVID-19 / group, cell type (main and fine annotations) | 3.97e-04 | 195 | 33 | 3 | 603050beeb33c331d4b2e3fa46cae3f3e0e4bdc7 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.97e-04 | 195 | 33 | 3 | b3660779f274ca97dd844cf83f62d85ba88cb182 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.97e-04 | 195 | 33 | 3 | 4243190ad291d56694e2155954dbaa879c9d3844 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-tracheobronchial_smooth_muscle_cell-Smooth_muscle-Smooth_muscle_L.2.3.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.97e-04 | 195 | 33 | 3 | 7155cc12cc6a97efd626bbdb95249fb3d7041dcf | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.97e-04 | 195 | 33 | 3 | aa0add081881d349099d12efca5cdee098038d4e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.97e-04 | 195 | 33 | 3 | 0bdf845939bc4b8cc94f2808aea60f818425b076 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.97e-04 | 195 | 33 | 3 | df409f94f4e83be89f7a608058ee07ce3ce3a149 | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-04 | 196 | 33 | 3 | 6d7179decea512dd49bb2d5f6a4f5989349d52a9 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.03e-04 | 196 | 33 | 3 | c390ef0adff35111989a30dff86b7c5db1a89873 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 196 | 33 | 3 | 9a90dd26e7a43e3fd55e7c5d8354cfa4cdd5a6cc | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-04 | 196 | 33 | 3 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | 367C-Fibroblasts-Fibroblast-K_(Pericytes)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.03e-04 | 196 | 33 | 3 | 2f76f050083483f0880639e6c34ff349caac3503 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-04 | 196 | 33 | 3 | cecf82cd5e0a3835d655f5e7478578674a63ce25 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.03e-04 | 196 | 33 | 3 | 9737a5f006d37b549f281e1863aca558e1e4dc99 | |
| ToppCell | Children_(3_yrs)-Mesenchymal|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.03e-04 | 196 | 33 | 3 | bc94909f9b2dc08a59eef1914148b69720569c8f | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.03e-04 | 196 | 33 | 3 | 04dfef1bd4ebb0e9469ae80024dc177e469a2560 | |
| ToppCell | Pericytes|World / shred by cell class for parenchyma | 4.03e-04 | 196 | 33 | 3 | 8e7ecbe77d312a7fc6aadd8fd52c13dd1834cc7e | |
| ToppCell | 5'-Adult-SmallIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.03e-04 | 196 | 33 | 3 | ce6f7ddb8104471dc90347f427486379914d63b4 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.03e-04 | 196 | 33 | 3 | 7d8505dac15fa59935ccf592afc54b04c4c6554f | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.09e-04 | 197 | 33 | 3 | 94a9603cbd3516fbcce871909693b88f20d41713 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Alveolar_fibroblasts-Alveolar_fibroblasts_L.2.1.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.09e-04 | 197 | 33 | 3 | 13896ec65ccda0b928c91d41112dc01b480036b7 | |
| ToppCell | droplet-Bladder-nan-24m-Endothelial-endothelial_cell|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.09e-04 | 197 | 33 | 3 | 488e85991c5e668afb7672942726d9295b8fc7d8 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes-Contractile_pericyte_(PLN+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-04 | 197 | 33 | 3 | d16bb765afdc02406ffd7ce6a75bae72b66db66c | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-Pericytes|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.09e-04 | 197 | 33 | 3 | 68c23c23b6924892f4c238cf2f5abc7927e04fbc | |
| ToppCell | Bronchial-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.16e-04 | 198 | 33 | 3 | 705118a5db366b43ffd3389c60e4cb392ad3f2e6 | |
| ToppCell | cellseq-Mesenchymal-Myocytic-Myocytic_2-VSMC|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.16e-04 | 198 | 33 | 3 | e967c601101361fc1c48dab0e5b76dc68813276e | |
| ToppCell | nucseq-Mesenchymal|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.16e-04 | 198 | 33 | 3 | 8f52243ca8b9ba68a75ae411506a3a6de258eb97 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.16e-04 | 198 | 33 | 3 | 6d18b45eda4014759e6dd282d78ffd28df8a6044 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-1M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-1M / Sample Type, Dataset, Time_group, and Cell type. | 4.16e-04 | 198 | 33 | 3 | b73b9feb82997b654718aa27f33ca7b454214802 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.16e-04 | 198 | 33 | 3 | c01091ef18e096d792ea2a7a715764a5b215355f | |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.16e-04 | 198 | 33 | 3 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 | |
| ToppCell | Adult-Mesenchymal|Adult / Lineage, Cell type, age group and donor | 4.16e-04 | 198 | 33 | 3 | 26e55b409db2a1637c95fae7c54b0abea1ef550c | |
| ToppCell | Tracheal-10x5prime-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.16e-04 | 198 | 33 | 3 | 1e1ea54f0c234f3b6d29064c4881d8a0c0949a75 | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.16e-04 | 198 | 33 | 3 | f1374f7a50244d59c766ac41f44c08c9117407d2 | |
| Computational | Genes in the cancer module 98. | 4.84e-04 | 393 | 19 | 5 | MODULE_98 | |
| Computational | TFs and nuclear. | 6.88e-04 | 237 | 19 | 4 | MODULE_252 | |
| Computational | Genes in the cancer module 198. | 1.72e-03 | 303 | 19 | 4 | MODULE_198 | |
| Computational | Genes in the cancer module 11. | 2.03e-03 | 540 | 19 | 5 | MODULE_11 | |
| Computational | Genes in the cancer module 100. | 2.10e-03 | 544 | 19 | 5 | MODULE_100 | |
| Computational | CNS genes. | 2.13e-03 | 546 | 19 | 5 | MODULE_137 | |
| Computational | Genes in the cancer module 66. | 2.24e-03 | 552 | 19 | 5 | MODULE_66 | |
| Computational | Genes in the cancer module 197. | 3.34e-03 | 174 | 19 | 3 | MODULE_197 | |
| Drug | 3,4-dihydroquinazoline | 5.53e-08 | 6 | 33 | 3 | CID000583065 | |
| Drug | AC1L2VU3 | 6.05e-07 | 12 | 33 | 3 | CID000129572 | |
| Drug | enzacamene | 1.13e-06 | 129 | 33 | 5 | ctd:C038939 | |
| Drug | pentasulfane | 1.53e-06 | 16 | 33 | 3 | CID000448216 | |
| Drug | octylmethoxycinnamate | 1.63e-06 | 139 | 33 | 5 | ctd:C118580 | |
| Drug | procymidone | 2.79e-06 | 155 | 33 | 5 | ctd:C035988 | |
| Drug | butylparaben | 2.97e-06 | 157 | 33 | 5 | ctd:C038091 | |
| Drug | 1,3-dioxoisoindoline-5-carboxamide | 6.11e-06 | 3 | 33 | 2 | CID010679219 | |
| Drug | CNS 1145 | 1.47e-05 | 33 | 33 | 3 | CID000190902 | |
| Drug | IHC-64 | 1.47e-05 | 33 | 33 | 3 | CID000162753 | |
| Drug | loperamide | 1.58e-05 | 105 | 33 | 4 | CID000003954 | |
| Drug | Flunarizine | 2.03e-05 | 5 | 33 | 2 | DB04841 | |
| Drug | Linuron | 3.44e-05 | 128 | 33 | 4 | ctd:D008044 | |
| Drug | LY215840 | 4.26e-05 | 7 | 33 | 2 | CID000132049 | |
| Drug | KW-3049 | 5.19e-05 | 50 | 33 | 3 | CID000002324 | |
| Drug | isovalerate | 5.30e-05 | 143 | 33 | 4 | CID000010430 | |
| Drug | nimodipine | 5.59e-05 | 145 | 33 | 4 | CID000004497 | |
| Drug | Bepridil | 5.67e-05 | 8 | 33 | 2 | DB01244 | |
| Drug | Cinnarizine | 7.29e-05 | 9 | 33 | 2 | DB00568 | |
| Drug | Cinildipine | 7.30e-05 | 56 | 33 | 3 | CID000002752 | |
| Drug | nilvadipine | 8.97e-05 | 60 | 33 | 3 | CID000004494 | |
| Drug | hydroxyephedrine | 9.10e-05 | 10 | 33 | 2 | CID000009701 | |
| Drug | IAA-94 | 9.43e-05 | 61 | 33 | 3 | CID000003667 | |
| Drug | gabapentin | 1.01e-04 | 169 | 33 | 4 | CID000003446 | |
| Drug | lercanidipine | 1.04e-04 | 63 | 33 | 3 | CID000065866 | |
| Drug | Mibefradil | 1.11e-04 | 11 | 33 | 2 | DB01388 | |
| Drug | EBNs | 1.11e-04 | 11 | 33 | 2 | CID000150695 | |
| Drug | AC1L1TJF | 1.19e-04 | 66 | 33 | 3 | CID000003377 | |
| Drug | Methoxychlor | 1.22e-04 | 549 | 33 | 6 | ctd:D008731 | |
| Drug | gallopamil | 1.25e-04 | 67 | 33 | 3 | CID000001234 | |
| Drug | themisone | 1.33e-04 | 12 | 33 | 2 | CID000016235 | |
| Drug | AC1L2AC7 | 1.36e-04 | 69 | 33 | 3 | CID000068733 | |
| Drug | Barium | 1.55e-04 | 72 | 33 | 3 | ctd:D001464 | |
| Drug | tetralol | 1.57e-04 | 13 | 33 | 2 | CID000010747 | |
| Drug | Mibefradil | 1.57e-04 | 13 | 33 | 2 | ctd:D020748 | |
| Drug | guanosine 3',5'-cyclic monophosphoric acid | 1.60e-04 | 577 | 33 | 6 | CID000000295 | |
| Drug | CAS 298-57-7 | 1.61e-04 | 73 | 33 | 3 | CID000002761 | |
| Drug | ethosuximide | 1.68e-04 | 74 | 33 | 3 | CID000003291 | |
| Drug | Streptozotocin [18883-66-4]; Up 200; 15uM; PC3; HT_HG-U133A | 1.72e-04 | 194 | 33 | 4 | 5836_UP | |
| Drug | Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 1.72e-04 | 194 | 33 | 4 | 2828_UP | |
| Drug | Decamethonium bromide [541-22-0]; Down 200; 9.6uM; MCF7; HT_HG-U133A | 1.72e-04 | 194 | 33 | 4 | 4174_DN | |
| Drug | Dihydroergocristine mesylate [24730-10-7]; Up 200; 5.6uM; MCF7; HT_HG-U133A | 1.76e-04 | 195 | 33 | 4 | 2895_UP | |
| Drug | Clomiphene citrate (Z,E) [50-41-9]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 1.76e-04 | 195 | 33 | 4 | 2624_UP | |
| Drug | GSK-3 Inhibitor IX; Up 200; 0.5uM; MCF7; HT_HG-U133A | 1.76e-04 | 195 | 33 | 4 | 7101_UP | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; HL60; HT_HG-U133A | 1.79e-04 | 196 | 33 | 4 | 2961_UP | |
| Drug | Dizocilpine maleate [77086-22-7]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 1.79e-04 | 196 | 33 | 4 | 2232_DN | |
| Drug | Lisinopril [83915-83-7]; Up 200; 9uM; HL60; HT_HG-U133A | 1.83e-04 | 197 | 33 | 4 | 2371_UP | |
| Drug | Fludrocortisone acetate [514-36-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | 1.83e-04 | 197 | 33 | 4 | 2328_DN | |
| Drug | Ni-B | 1.83e-04 | 14 | 33 | 2 | CID000039502 | |
| Drug | Trapidil [15421-84-8]; Up 200; 19.4uM; MCF7; HT_HG-U133A | 1.86e-04 | 198 | 33 | 4 | 7475_UP | |
| Drug | Aceclofenac [89796-99-6]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.86e-04 | 198 | 33 | 4 | 2281_DN | |
| Drug | Lasalocid sodium salt [25999-20-6]; Down 200; 6.6uM; MCF7; HT_HG-U133A | 1.90e-04 | 199 | 33 | 4 | 3360_DN | |
| Drug | nisoldipine | 1.96e-04 | 78 | 33 | 3 | CID000004499 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 2.04e-04 | 79 | 33 | 3 | CID005287890 | |
| Drug | butamben | 2.11e-04 | 15 | 33 | 2 | CID000002482 | |
| Drug | Verapamil | 2.41e-04 | 16 | 33 | 2 | DB00661 | |
| Drug | difluoroboron | 2.44e-04 | 84 | 33 | 3 | CID000139622 | |
| Drug | Zonisamide | 2.73e-04 | 17 | 33 | 2 | DB00909 | |
| Drug | cyclopropanecarboxylic acid | 3.43e-04 | 19 | 33 | 2 | CID000015655 | |
| Drug | manidipine | 3.51e-04 | 95 | 33 | 3 | CID000004008 | |
| Drug | isotetrandrine | 3.73e-04 | 97 | 33 | 3 | CID000005422 | |
| Drug | homovanillic acid | 3.73e-04 | 97 | 33 | 3 | CID000001738 | |
| Drug | nitrendipine | 3.84e-04 | 98 | 33 | 3 | CID000004507 | |
| Drug | isradipine | 4.08e-04 | 100 | 33 | 3 | CID000003784 | |
| Drug | stannous ion | 4.20e-04 | 21 | 33 | 2 | CID000104883 | |
| Drug | pyraclofos | 4.83e-04 | 106 | 33 | 3 | CID000093460 | |
| Disease | Epilepsy, Cryptogenic | 3.27e-08 | 82 | 33 | 5 | C0086237 | |
| Disease | Awakening Epilepsy | 3.27e-08 | 82 | 33 | 5 | C0751111 | |
| Disease | Aura | 3.27e-08 | 82 | 33 | 5 | C0236018 | |
| Disease | Neurodevelopmental Disorders | 6.17e-08 | 93 | 33 | 5 | C1535926 | |
| Disease | Epilepsy | 1.37e-07 | 109 | 33 | 5 | C0014544 | |
| Disease | Mental Retardation, Psychosocial | 1.74e-05 | 139 | 33 | 4 | C0025363 | |
| Disease | Profound Mental Retardation | 1.74e-05 | 139 | 33 | 4 | C0020796 | |
| Disease | Mental deficiency | 1.74e-05 | 139 | 33 | 4 | C0917816 | |
| Disease | Absence Epilepsy | 2.54e-05 | 7 | 33 | 2 | C0014553 | |
| Disease | Akinetic Petit Mal | 2.54e-05 | 7 | 33 | 2 | C0001890 | |
| Disease | Epilepsy, Absence, Atypical | 2.54e-05 | 7 | 33 | 2 | C0751124 | |
| Disease | Childhood Absence Epilepsy | 2.54e-05 | 7 | 33 | 2 | C4281785 | |
| Disease | Absence Seizure Disorder | 2.54e-05 | 7 | 33 | 2 | C4553705 | |
| Disease | Juvenile Absence Epilepsy | 2.54e-05 | 7 | 33 | 2 | C4317339 | |
| Disease | Epilepsy, Minor | 2.54e-05 | 7 | 33 | 2 | C4552765 | |
| Disease | cortical surface area measurement | 9.13e-05 | 1345 | 33 | 8 | EFO_0010736 | |
| Disease | intellectual disability (is_implicated_in) | 5.17e-04 | 30 | 33 | 2 | DOID:1059 (is_implicated_in) | |
| Disease | Epileptic encephalopathy | 5.17e-04 | 30 | 33 | 2 | C0543888 | |
| Disease | autism spectrum disorder (implicated_via_orthology) | 6.53e-04 | 152 | 33 | 3 | DOID:0060041 (implicated_via_orthology) | |
| Disease | Ataxia, Spinocerebellar | 6.65e-04 | 34 | 33 | 2 | C0087012 | |
| Disease | Spinocerebellar Ataxia Type 2 | 6.65e-04 | 34 | 33 | 2 | C0752121 | |
| Disease | Spinocerebellar Ataxia Type 1 | 6.65e-04 | 34 | 33 | 2 | C0752120 | |
| Disease | Spinocerebellar Ataxia Type 5 | 6.65e-04 | 34 | 33 | 2 | C0752123 | |
| Disease | Spinocerebellar Ataxia Type 7 | 6.65e-04 | 34 | 33 | 2 | C0752125 | |
| Disease | Spinocerebellar Ataxia Type 6 (disorder) | 6.65e-04 | 34 | 33 | 2 | C0752124 | |
| Disease | Spinocerebellar Ataxia Type 4 | 7.05e-04 | 35 | 33 | 2 | C0752122 | |
| Disease | diet measurement | 9.68e-04 | 1049 | 33 | 6 | EFO_0008111 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KHRQHHHHHHHHHHP | 2206 | O00555 | |
| QHHHHHHAHHHHHHA | 166 | Q8NFD5 | |
| HHAHHHHHHAHHLHH | 171 | Q8NFD5 | |
| HHHHAHHLHHHHALQ | 176 | Q8NFD5 | |
| NHHHHHNHHSHKHSH | 516 | O60563 | |
| HHGNSSHHHHHHHHH | 601 | Q13627 | |
| SHHHHHHHHHHHHHG | 606 | Q13627 | |
| RHEHHHHHEHHHHYH | 451 | Q969G9 | |
| HHHPHHHHHHHAAAH | 141 | Q5VYV0 | |
| HHHHHHAAAHHHHHH | 146 | Q5VYV0 | |
| AAHHHHAAHHHHHHH | 191 | Q8NHW3 | |
| HAAHHHHHHHHHHGG | 196 | Q8NHW3 | |
| SSTHHHHHHHHHGHS | 1236 | Q5JU85 | |
| NSHHPQHHHHHHHHH | 41 | P55316 | |
| HHHHHHHHHPHHHQR | 126 | Q9UBC0 | |
| QHHPKHHHHHHHHHH | 166 | Q5HYJ3 | |
| HHHHHHHHHHRHSSS | 171 | Q5HYJ3 | |
| ASQHHRGHHHHHHHH | 61 | P50222 | |
| RGHHHHHHHHHHHHH | 66 | P50222 | |
| HHHHHHHHHHQQQQH | 71 | P50222 | |
| HHYHHHHHHHHHRSP | 921 | O15083 | |
| HEHHHHHEHHHHHHH | 431 | Q969F2 | |
| HHEHHHHHHHHHFHP | 436 | Q969F2 | |
| GHHHHHHHHHHQGYG | 291 | P32242 | |
| RRHHHHNHHHHHNRH | 511 | O43900 | |
| VHHLVHHHHHHHHHY | 491 | O43497 | |
| HHHHHHHHHYHLGNG | 496 | O43497 | |
| TSHHHHHHHHHHHHQ | 221 | O95886 | |
| HHHHHHHHHQSRHGK | 226 | O95886 | |
| PHPHHHHHHHHHHHH | 386 | O00257 | |
| HHHHHHHHHHAVGLN | 391 | O00257 | |
| RHRHHRHHHHHHHHR | 71 | Q3B7T3 | |
| HLVYHHHHHHHHHYH | 516 | O95180 | |
| HHHHHHHHYHFSHGS | 521 | O95180 | |
| APSYHHHHHHHHHHH | 91 | Q92570 | |
| HHHHHHHHHHHHHQQ | 96 | Q92570 | |
| ALAGTHHHHHHHHHH | 166 | Q12837 | |
| HHHHHHHHHHHHQPH | 171 | Q12837 | |
| RRHHHHHQHHHQHHH | 1281 | O14594 | |
| PHHHHHHHHHHHHHH | 336 | Q1XH10 | |
| HHHHHHHHHHHRAQP | 341 | Q1XH10 | |
| HHLSHHHCHHRHHHH | 66 | Q8IW03 | |
| HHCHHRHHHHLRHHA | 71 | Q8IW03 | |
| YGSSHHHHHHHHHHH | 636 | O94875 | |
| HHHHHHHHHHRHLIS | 641 | O94875 | |
| HHHHDYHHILHHHHH | 556 | Q13433 | |
| GHHHHHHHHHHHTSQ | 86 | O60481 | |
| QQHGHHFQHHHHHHH | 506 | Q6ZNA4 | |
| SHHHHHHHHHHRGGE | 956 | Q96PV0 | |
| GHAGHHHHHHHHHHH | 66 | P25490 | |
| GPQHHHHHHHHHHHH | 746 | Q70CQ2 | |
| HHHHHHHHHHDGHMV | 751 | Q70CQ2 |